Healthcare CRO Services Market Size Report, Share & Analysis 2027

Healthcare Contract Research Organizations (CRO) Services Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Service Type (Early Phase Development, Laboratory Services, Consulting Services, Clinical Research Services); Therapeutic Indication (Oncology, Infectious Diseases, Respiratory Diseases, Cardiovascular Diseases, Neurological Disorders, Others); End User (Medical Device Companies, Pharmaceutical and Biopharmaceutical Companies, Others); and Geography

  • Report Code : TIPRE00010465
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 223
Buy Now

[Research Report] The healthcare contract research organizations (CRO) services market was valued at US$ 43,208.57 million in 2019 and it is projected to reach US$ 87,859.08 million in 2027; it is expected to grow at a CAGR of 9.5% from 2020 to 2027.

Contract research organization (CRO) provides support services to the pharmaceutical, biotechnology, and medical device companies throughout the development of the product. Pharmaceutical& biotechnology companies and the medical device industry require various testing services such as preclinical services, clinical research services, analytical testing services, bio analytical testing services, and regulatory services. CROs are specifically designed to perform these testing services to reduce the in-house cost and time of the companies, required to conduct the extensive range of testing services to comply with the national and international regulatory standards. The growth of the global healthcare CRO services market is attributed to the increasing number of clinical trials and increasing expenditure in R&D and outsourcing activities. However, dearth of skilled professionals is the major factor hindering the healthcare CRO services market

growth.

 

Report Coverage



The global healthcare contract research organizations (CRO) services market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for Global Healthcare CRO Services Market



Lucrative Regions for Global Healthcare Contract Research Organizations (CRO) Services Market
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights

Rising Number of Clinical Trials to Drive Global Healthcare Contract Research Organizations (CRO) Services Market Growth

Clinical trials play a determinant role in drug approvals and its efficacy over diseases. The studies help in understanding best medical approaches in certain therapeutic areas. The healthcare systems across the world are observing rapid increase in the number of clinical trials. Factors such as growing demand for novel drugs and medical equipment, increasing prevalence of chronic conditions, and growth in funding programs to conduct clinical trials are responsible to propel the number of clinical trials across the world.

In addition, many of the companies focus on establishing partnerships with contract research organizations for carrying out clinical studies in an efficient way. For instance, in December 2019, Cyclo Therapeutics signed a service agreement with Worldwide Clinical Trials, a contract research organization to execute companies’ clinical programs, for the evaluation of Trappsol Cyclo a treatment for Alzheimer’s disease. Further, in May 2020, Daré Bioscience, Inc. entered into a strategic partnership with Health Decisions, Inc., a considerable contract research organization, to accelerate clinical studies under women’s health programs. Such growing number of collaborations will eventually increase the contribution of contract research organizations in the execution of clinical studies, which will eventually drive the market growth.

Service Type -Based Insights

In terms of service type, the global healthcare contract research organizations (CRO) services market is segmented into early phase development, laboratory services, consulting services, and clinical research services. In 2019, the clinical research services segment held largest share of the market. Also, the same segment is estimated to register the highest CAGR during the forecast period.

Global Healthcare CRO services Market, by Service Type– 2019 and 2027



Global Healthcare contract research organizations (CRO) services Market, by Service Type– 2019 and 2027
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

 

Therapeutic Indication -Based Insights

In terms of therapeutic indication, the global healthcare contract research organizations (CRO) services market is segmented into oncology, infectious diseases, immunological disorders, respiratory diseases, cardiovascular diseases, neurological disorders, and others. In 2019, the others segment held largest share of the market. However, the oncology segment is estimated to register the highest CAGR during the forecast period.

End User-Based Insights

In terms of end user, the global healthcare contract research organizations (CRO) services market is segmented into medical device companies, pharmaceutical and biopharmaceutical companies, others (academic institutes). The pharmaceutical and biopharmaceutical companies segment held the largest share of the market in 2019. Also, the same segment is estimated to grow at the highest CAGR during the forecast period.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Healthcare Contract Research Organizations (CRO) Services Market: Strategic Insights

healthcare-cro-services-market
Market Size Value inUS$ 43,208.57 Million in 2019
Market Size Value byUS$ 87,859.08 Million by 2027
Growth rateCAGR of 9.5% from 2020-2027
Forecast Period2020-2027
Base Year2020
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

The global healthcare CRO services market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

 

Global Healthcare CRO Services Market – by Service Type

  • Early Phase Development
    • Discovery Studies
    • Chemistry, Manufacturing, and Control
    • Pre-Clinical Services
  • Laboratory Services
    • Bio-analytical Testing
    • Analytical Testing
  • Consulting Services
  • Clinical Research Services
    • Phase I
    • Phase II
    • Phase III
    • Phase IV

Global Healthcare CRO Services Market – by Therapeutic Indication

  • Oncology
  • Infectious Diseases
  • Respiratory Diseases
  • Cardiovascular Diseases
  • Neurological Disorders
  • Others  

Global Healthcare CRO Services Market – by End- User

  • Medical Device Companies
  • Pharmaceutical and Biopharmaceutical Companies
  • Others (Academic Institutes)

Global Healthcare CRO Services Market – by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Charles River Laboratories, Inc.
  • Iqvia Inc.
  • Laboratory Corporation of America Holdings
  • Parexel International Corporation
  • Icon Plc
  • PRA Health Sciences
  • Syneos Health
  • Medpace
  • Wuxi Apptec
  • PPD Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Service Type ; Therapeutic Indication ; End User ; and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What are the driving factors for the Healthcare Contract Research Organization (CRO) services market across the globe?

Factors like growing number of clinical trials and increasing expenditure in R&D and outsourcing activities are driving the growth of the market. In addition, rising biosimilars and biologics market are likely to have a positive impact on the growth of the market in the coming years.

What is the average cost of a clinical trial?

The clinical trials cost a median of $41,117 per patient and $3,562 per patient visit. Clinical trial cost varies with the therapeutic area, phase of study and region where the clinical trial is being conducted.

What are Healthcare Contract Research Organization (CRO)?

Contract research organization (CRO) provides support services to the pharmaceutical, biotechnology, and medical device companies throughout the development of the product. Pharmaceutical& biotechnology companies and the medical device industry require various testing services such as preclinical services, clinical research services, analytical testing services, bio analytical testing services, and regulatory services. CROs are specifically designed to perform these testing services to reduce the in-house cost and time of the companies, required to conduct the extensive range of testing services to comply with the national and international regulatory standards..

The List of Companies - Healthcare Contract Research Organizations (CRO) Services Market

  1. Charles River Laboratories Inc.
  2. IQVIA Inc.
  3. Laboratory Corporation of America Holdings
  4. Parexel International Corporation
  5. Icon Plc.
  6. Pra Health Sciences
  7. Syneos Health
  8. Medpace
  9. Wuxi Apptec
  10. PPD Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Healthcare Contract Research Organizations (CRO) Services Market